Skip to main content

RV001: An anti-metastatic cancer vaccine

Deliverables

Dissemination and communication plan

D42 Dissemination and communication plan M6 updated every six months

Searching for OpenAIRE data...

Publications

Vaccination against RhoC induces long-lasting immune responses in patients with prostate cancer: results from a phase I/II clinical trial

Author(s): Juliane Schuhmacher, Sonja Heidu, Torben Balchen, Jennifer Rebecca Richardson, Camilla Schmeltz, Jesper Sonne, Jonas Schweiker, Hans-Georg Rammensee, Per Thor Straten, Martin Andreas Røder, Klaus Brasso, Cécile Gouttefangeas
Published in: Journal for ImmunoTherapy of Cancer, 8/2, 2020, Page(s) e001157, ISSN 2051-1426
Publisher: Journal of Immunotherapy of cancer
DOI: 10.1136/jitc-2020-001157